<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2004-4-21-25</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-3702</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ И КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL AND CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Особенности воспалительной реакции при коллагенозах</article-title><trans-title-group xml:lang="en"><trans-title>Peculiarities of inflammatory response during collagenosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трофименко</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Trofimenko</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центральная научно-исследовательская лаборатория</p><p>г. Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зорина</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zorina</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центральная научно-исследовательская лаборатория</p><p>г. Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Архипова</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Arkhipova</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центральная научно-исследовательская лаборатория</p><p>г. Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбатовский</surname><given-names>Я. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbatovsky</surname><given-names>Ya. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центральная научно-исследовательская лаборатория</p><p>г. Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зорина</surname><given-names>Р. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zorina</surname><given-names>R. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Центральная научно-исследовательская лаборатория</p><p>г. Новокузнецк</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Новокузнецкий государственный институт усовершенствования врачей Минздрава РФ</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2004</year></pub-date><volume>3</volume><issue>4</issue><fpage>21</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Трофименко Н.А., Зорина В.Н., Архипова С.В., Горбатовский Я.А., Зорина Р.М., 2004</copyright-statement><copyright-year>2004</copyright-year><copyright-holder xml:lang="ru">Трофименко Н.А., Зорина В.Н., Архипова С.В., Горбатовский Я.А., Зорина Р.М.</copyright-holder><copyright-holder xml:lang="en">Trofimenko N.A., Zorina V.N., Arkhipova S.V., Gorbatovsky Y.A., Zorina R.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/3702">https://bulletin.ssmu.ru/jour/article/view/3702</self-uri><abstract><p>Исследованы концентрации цитокинов (ИЛ-1β, ИЛ-6, ФНО-α) α2-макроглобулина (МГ), плазминогена (ПЛ) α1-антитрипсина (АТ), общего белка, альбумина и мочевой кислоты в сыворотке крови пациентов с коллагенозами с целью изучения их комплексного взаимодействия и возможности их использования при дифференциальной диагностике. Исследована сыворотка крови 60 здоровых доноров, 53 пациентов с ревматоидным артритом (РА), 15 пациентов с реактивным артритом (РЕА) и 16 больных с системной красной волчанкой (СКВ). Концентрации ИЛ-1β, ИЛ-6 и ФНО-α определялись ELISA, МГ, АТ и ПЛ-ракетным иммуноэлектрофорезом, общий белок, альбумин и мочевая кислота — биохимическими методами. Уровень альбумина снижался у всех групп пациентов. Концентрация общего белка снижалась только при 1-й степени активности РА. Уровни МГ, АТ и ПЛ не различались при всех заболеваниях по сравнению с контролем. Концентрация ИЛ-6 значительно увеличивалась у всех групп больных. ФНО-α рос при утяжелении РА, но только при самой тяжелой степени статистически значимо  отличался  от  РЕА  и  СКВ.  Схожие  тенденции  демонстрировала  концентрация ИЛ-1β в случае с РА и СКВ, но при РЕА выявлены большие индивидуальные колебания с высоким средним уровнем. Синхронное изменение концентраций изучаемых цитокинов без сопутствующего изменения уровня МГ свидетельствуют о повреждении транспортных и регуляторных функций данного белка. Мочевая кислота может быть использована для диагностики СКВ, динамическое наблюдение за концентрациями ИЛ-1β и ФНО-α может служить  прогностическим  критерием при РА.</p></abstract><trans-abstract xml:lang="en"><p>Concentrations of cytokines (IL-1β, IL-6, TNF-α) of α2-macroglobulin (MG), α1-antitrypsin (AT) plasminogen (PL), whole protein, albumin and uric acid in blood serum of patients with collagenosis have been investigated aiming the study of their complex interaction and the possibility of their use during differential diagnostics. The blood serum of 60 healthy donors, 53 patients with rheumatoid arthritis (RA), 15 patients with reactive arthritis (REA) and 16 patients with systemic lupus erythematosus (SLE) has been studied. IL-1β, IL-6 and TNF-α concentrations have been defined by ELISA, MG, AT and PL-rocket immunoelectrophoresis, the whole protein, albumin and uric acid — by biochemical methods. The albumin level decreased in all groups of patients. The whole protein concentration decreased at the first RA activity degree. MG, AT and PL levels had no difference at all diseases as compared to the control group. IL-6 concentration increased significantly at all patients groups. TNF-α increased with the RA severity but differed statistically significantly from REA and SLE only at the most severe degree. Analogous trends in IL-1β concentration have been found in cases of RA and SLE but at REA great individual fluctuations with the high average level have been found. Synchronous change of the studied cytokine concentrations without associated MG level change is evidence of the damage of traffic and regulatory functions of this protein. The uric acid can be used for SLE diagnostics and the dynamic supervision of IL-1β and TNF-α can be a prognostic criterion at RA.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>коллагенозы</kwd><kwd>ревматоидный артрит</kwd><kwd>реактивный артрит</kwd><kwd>СКВ</kwd><kwd>цитокин</kwd><kwd>белки острой фазы</kwd><kwd>воспаление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>collagenosis</kwd><kwd>rheumatoid arthritis</kwd><kwd>reactive arthritis</kwd><kwd>SLE</kwd><kwd>cytokine</kwd><kwd>acute phase proteins</kwd><kwd>inflammation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ревматические болезни / Под ред. В.А. Насонова, Н.В. Бунчук. М: Медицина, 1997.</mixed-citation><mixed-citation xml:lang="en">Ревматические болезни / Под ред. В.А. Насонова, Н.В. Бунчук. М: Медицина, 1997.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Baier A., Meineckel I., Gay S., Pap T. Apoptosis in rheumatoid arthritis // Curr. Opin. Rheumatol. 2003. V. 1. ‹ 3. P. 274—279.</mixed-citation><mixed-citation xml:lang="en">Baier A., Meineckel I., Gay S., Pap T. Apoptosis in rheumatoid arthritis // Curr. Opin. Rheumatol. 2003. V. 1. ‹ 3. P. 274—279.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bingham C.O. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation // J. Rheumatol. Suppl. 2002. V. 65. P. 3—9.</mixed-citation><mixed-citation xml:lang="en">Bingham C.O. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation // J. Rheumatol. Suppl. 2002. V. 65. P. 3—9.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Birkenmeier G. Targetting the proteinase inhibitor and immune modulatory function of human alpha 2-macroglobulin // Mod. Asp. Immunobiol. 2001. V. 2. P. 32—36.</mixed-citation><mixed-citation xml:lang="en">Birkenmeier G. Targetting the proteinase inhibitor and immune modulatory function of human alpha 2-macroglobulin // Mod. Asp. Immunobiol. 2001. V. 2. P. 32—36.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cheon H., Yu S.J., Yoo D.H. et al. Increased expression of proinflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals // Clin. Exp. Immunol. 2002. V. 127. ‹ 3. P. 547—552.</mixed-citation><mixed-citation xml:lang="en">Cheon H., Yu S.J., Yoo D.H. et al. Increased expression of proinflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals // Clin. Exp. Immunol. 2002. V. 127. ‹ 3. P. 547—552.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cvetkovic J.T., Wallberg-Jonsson S., Stegmayr B. et al. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphism of the TNF-alpha, IL-1beta, and IL-1Ra genes // J. Rheumatol. 2002. V. 29. ‹ 2. P. 212—219.</mixed-citation><mixed-citation xml:lang="en">Cvetkovic J.T., Wallberg-Jonsson S., Stegmayr B. et al. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphism of the TNF-alpha, IL-1beta, and IL-1Ra genes // J. Rheumatol. 2002. V. 29. ‹ 2. P. 212—219.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dayer J.M. The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis // Joint Bone Spine. 2002. V. 69. ‹ 2. P. 123—132.</mixed-citation><mixed-citation xml:lang="en">Dayer J.M. The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis // Joint Bone Spine. 2002. V. 69. ‹ 2. P. 123—132.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Desser L., Holomanova D., Zavadova E. et al. Oral therapy with proteolytic enzymes decrease excessive TGF-beta levels in human blood // Cancer Chemother. Pharmacol. 2001. V. 47(Suppl. 1). P. 10—15.</mixed-citation><mixed-citation xml:lang="en">Desser L., Holomanova D., Zavadova E. et al. Oral therapy with proteolytic enzymes decrease excessive TGF-beta levels in human blood // Cancer Chemother. Pharmacol. 2001. V. 47(Suppl. 1). P. 10—15.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Goulin-Charnet A., Laune D., Granier C., Mani J.C., Pau B., Mourad G., Argiles A. Alpha 2-macroglobulin, the main serum antiprotease, binds beta 2-microglobulin, the light chain of the class I major histocomparibility complex, which is involved in human disease // J. Clin. Sci. (Lond.). 2000. V. 98. P. 427—433.</mixed-citation><mixed-citation xml:lang="en">Goulin-Charnet A., Laune D., Granier C., Mani J.C., Pau B., Mourad G., Argiles A. Alpha 2-macroglobulin, the main serum antiprotease, binds beta 2-microglobulin, the light chain of the class I major histocomparibility complex, which is involved in human disease // J. Clin. Sci. (Lond.). 2000. V. 98. P. 427—433.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Maltseva N.V., Zorin N.A. The comparison of immunoregulatory proper-ties of alpha 2-macroglobulin and pregnancy-associated alpha 2-glycoprotein //Rus. J. Immunol. 1997. V. 2. ‹ 2. P. 97—102.</mixed-citation><mixed-citation xml:lang="en">Maltseva N.V., Zorin N.A. The comparison of immunoregulatory proper-ties of alpha 2-macroglobulin and pregnancy-associated alpha 2-glycoprotein //Rus. J. Immunol. 1997. V. 2. ‹ 2. P. 97—102.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Moore A.R., Appelboam A., Kawabata K. et al. Destruction of articular cartilage by alpha 2-macroglobulinelastase complexes: role in rheumatoid arthritis // Ann. Rheum. Dis. 1999. V. 58. ‹ 2. P. 109—113.</mixed-citation><mixed-citation xml:lang="en">Moore A.R., Appelboam A., Kawabata K. et al. Destruction of articular cartilage by alpha 2-macroglobulinelastase complexes: role in rheumatoid arthritis // Ann. Rheum. Dis. 1999. V. 58. ‹ 2. P. 109—113.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pantsulaia I., Trofimov S., Kobylansky E., Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population // Cytokine. 2002. V. 19. ‹ 3. P. 138—146.</mixed-citation><mixed-citation xml:lang="en">Pantsulaia I., Trofimov S., Kobylansky E., Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population // Cytokine. 2002. V. 19. ‹ 3. P. 138—146.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Scuderi F., Convertino R., Molino N. et al. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus // Autoimmunity. 2003. V. 36. ‹ 2. P. 71—77.</mixed-citation><mixed-citation xml:lang="en">Scuderi F., Convertino R., Molino N. et al. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus // Autoimmunity. 2003. V. 36. ‹ 2. P. 71—77.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Straub R.H., Paimela L., Peltomaa R. et al. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis // Arthritis Rheum. 2002. V. 46. ‹ 3. P. 654—662.</mixed-citation><mixed-citation xml:lang="en">Straub R.H., Paimela L., Peltomaa R. et al. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis // Arthritis Rheum. 2002. V. 46. ‹ 3. P. 654—662.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wu S.M., Pizzo S.V. Mechanism of hypochloritemediated inactivation of proteinase inhibition by alpha 2-macroglobulin // Biochemistry. 1999. V. 38. ‹ 42. P. 13983—13990.</mixed-citation><mixed-citation xml:lang="en">Wu S.M., Pizzo S.V. Mechanism of hypochloritemediated inactivation of proteinase inhibition by alpha 2-macroglobulin // Biochemistry. 1999. V. 38. ‹ 42. P. 13983—13990.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zorina V.N., Levchenko V.G., Zorina R.M. et al. Pregnancy-associated plasma protein A, alpha 2-macroglobulin, pregnancy zone protein and their complexes with IgG in sera of healthy nonpregnant and pregnant woman, and patients with breast cancer // Russian J. Immunol. 2001. V. 6. ‹ 1. P. 71—76.</mixed-citation><mixed-citation xml:lang="en">Zorina V.N., Levchenko V.G., Zorina R.M. et al. Pregnancy-associated plasma protein A, alpha 2-macroglobulin, pregnancy zone protein and their complexes with IgG in sera of healthy nonpregnant and pregnant woman, and patients with breast cancer // Russian J. Immunol. 2001. V. 6. ‹ 1. P. 71—76.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
